The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity

International Journal of Obesity

Volumn 25, Issue 6, 2001, Pages 781-792

  Flint, A ^a   Raben, A ^a   Ersboll A K ^a   Holst, J J ^b   Astrup, A ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Energy intake; GIP; GLP 1; GLP 2; Glucagon; Hunger; Insulin; Oxidation; Resting metabolic rate; Satiety; Thermogenesis

Indexed keywords

FATTY ACID; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON LIKE PEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; GLUCAGON LIKE PEPTIDE 2; GLUCOSE; INSULIN; LACTIC ACID; SODIUM CHLORIDE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; APPETITE; ARTICLE; BASAL METABOLIC RATE; CALORIC INTAKE; CARBOHYDRATE METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; ENERGY METABOLISM; GASTROINTESTINAL MOTILITY; GLUCAGON RELEASE; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HUNGER; INSULIN LIKE ACTIVITY; INSULIN METABOLISM; MALE; OBESITY; OXIDATION; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STOMACH EMPTYING; WEIGHT REDUCTION;

EID: 0034951506     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801627     Document Type: Article

References (50)

1. Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry
2. Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man
3. Glucagon-like peptide-1 7-36: A physiological incretin in man
4. Glucagon-like peptide-1 (7-36) amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: Acute post-prandial and 24-h secretion patterns
5. Glucagon-like peptide-1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut
6. Secretion of the incretin hormones glucagon-like peptide-1 and gastric inhibitory polypeptide correlates with insulin secretion in normal man throughout the day
7. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans
8. Glucagon-like peptide-1 (GLP-1) increases the period of postprandial satiety and Mows gastric emptying in obese humans
9. Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men
10. Glucagon-like peptide-1: A potent regulator of food intake in humans
11. GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in man
12. 2: A physiological inhibitor of gastric acid secretion in man
13. Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man
14. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans
15. Differential effects of intracerebroventricular glucagon-like peptide-1 on feeding and energy expenditure regulation
16. Effects of glucagon-like peptide 1 (7-36 amide) on whole-body protein metabolism in healthy man
17. The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans
18. Lower activity of oxidative key enzymes and smaller fiber areas in skeletal muscle of post-obese women
19. Reproducibility, validity and power of visual analogue scales in assessment of subjective appetite sensations in single meal test studies
20. Age and sex effects on energy expenditure
21. Carbohydrates for exercise: Dietary demands for optimal performance
22. An automated method for the measurement of oxygen consumption and carbon dioxide excretion in man
23. Energy expenditure and fuel selection in biological systems: The theory and practice of calculations based on indirect calorimetry and tracer methods
24. Triglycerides. Determination after enzymatic hydrolysis
25. Kinetic determination of serum glucose by use of the hexokinase/glucose-6-phosphate dehydrogenase method
26. L-(+)-Lactate. Determination with LDH, GPT and NAD
27. A sensitive precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties
28. Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide 1 in humans
29. Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine
30. Structure, analysis and secretion of human glucagon-like peptide-2 (GLP-2)
31. Diminished immunoreactive gastric inhibitory polypeptide response to a meal newly diagnosed type 1 (insulin-dependent) diabetics
32. Rapid, automatic, high capacity Dumas determination of nitrogen
33. No effect of glucagon-like peptide-1 on short-term satiety and energy intake in man
34. Central administration of GLP-1 (7-36) amide inhibits food and water intake in rats
35. Enteroglucagon
36. Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem
37. Glucagon-like peptide 1-a novel brain peptide involved in feeding regulation
38. A role for glucagon-like peptide-1 in the central regulation of feeding
39. Glucagon-like peptide 1 receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide 1
40. Leptin interacts with glucagon-like peptide-1 neurons to reduce food intake and body weight in rodents
41. Central infusions of leptin and GLP-1-(7-36) amide differentially stimulate c-FLI in the rat brain
42. A liquid mixed meal or exogenous glucagon-like peptide-1 (GLP-1) do not alter plasma leptin concentrations in healthy volunteers
43. Absence of short-term effects of glucagon-like peptide-1 and of hyperglycemia on plasma leptin levels in man
44. Glucagon-like peptide-1 (GLP-1): A trial of treatment in non-insulin-dependent diabetes mellitus
45. Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms
46. Gastrointestinal correlates of the development of hunger in man
47. The role of the gut in regulating food intake in man
48. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene